This effect contributes to the prohypertensive effects of abiraterone and can usually be successfully managed with a mineralocorticoid receptor antagonist.95 The mechanisms underlying enzalutamide-induced hypertension are still unclear. This evidence concerns the gene NR3C2 and Hypertension.